Skip to main content

Tag Influenza

WARF licenses influenza vaccine technology to FluGen

May 8, 2008

The Wisconsin Alumni Research Foundation and FluGen have signed license agreements for a technology that has the potential to significantly improve the way influenza vaccines are manufactured.

WARF, UW–Madison influenza researcher, Lentigen agree to donate technology

March 25, 2008

The University of Wisconsin–Madison has received a $1.3 million grant from the Bill & Melinda Gates Foundation to support research aimed at understanding the molecular features that lead to influenza pandemics. UW–Madison will collaborate with Maryland-based Lentigen Corp. on the project.

Drug-resistant flu virus emerges in untreated patients

April 3, 2007

Flu viruses with reduced sensitivity to the front-line drugs used to thwart and treat infection have been found in patients who were not treated with the drugs, according to an international team of researchers.

UW researcher and spinoff company to receive MIT technology awards

March 6, 2007

The MIT Club of Wisconsin, a state association for alumni of the Massachusetts Institute of Technology, is recognizing a University of Wisconsin–Madison influenza researcher and a bioscience spinoff company on Friday at its annual Technology Achievement Awards banquet.

Conference to advise businesses on pandemic preparation

September 14, 2006

A University of Wisconsin–Madison conference on Thursday, Oct. 12, "Surviving the Pandemic," is designed to help representatives from small- and medium-sized companies and nonprofit organizations assess their levels of preparedness and begin to develop their own company-specific plans.

Study of flu patients reveals virus outsmarting key drug

August 26, 2004

A drug envisioned as a front-line defense for the next flu pandemic might have a genetic Achilles' heel that results in a drug-resistant influenza virus capable of infecting new human hosts, according to a study published Aug. 28 in the British medical journal The Lancet.

Scientists solve puzzle of how influenza builds its infectious seeds

January 27, 2003

By solving a long-standing puzzle about how the influenza virus assembles its genetic contents into infectious particles that enable the virus to spread from cell to cell, scientists have opened a new gateway to a better understanding of one of the world's most virulent diseases.